Search Results - Yu KS

Refine Results
  1. 1

    Comparison of the Pharmacokinetics of Highly Variable Drugs in Healthy Subjects Using a Partial Replicated Crossover Study: A Fixed-Dose Combination of Fimasartan 120 mg and Atorva... by Hwang JG, Yu KS, Lee S

    Published in Drug Design, Development and Therapy (2020-05-01)
    Get full text
    Article


  2. 2

    Pharmacokinetic and Safety Profiles of MIT-001, a Novel Ferroptosis Inhibitor, After Subcutaneous Administration in Healthy Participants by Lee S, Bae S, Yu KS, Lee S

    Published in Drug Design, Development and Therapy (2025-09-01)
    Get full text
    Article


  3. 3

    Pharmacokinetics, Safety and Tolerability of Intravenous Lenzilumab, an Anti-GM-CSF Monoclonal Antibody Drug, in Healthy Korean Subjects by Kang J, Bae S, Yu KS, Lee S

    Published in Drug Design, Development and Therapy (2025-10-01)
    Get full text
    Article


  4. 4

    Pharmacokinetic interaction between fimasartan and atorvastatin in healthy male volunteers by Choi Y, Lee S, Jang IJ, Yu KS

    Published in Drug Design, Development and Therapy (2018-07-01)
    Get full text
    Article


  5. 5

    Evaluation of drug interactions between fimasartan and rosuvastatin after single and multiple doses in healthy Caucasians by Lee J, Rhee SJ, Lee S, Yu KS

    Published in Drug Design, Development and Therapy (2018-04-01)
    Get full text
    Article


  6. 6

    Development of a Fast Onset Proton Pump Inhibitor: Comparison of Fixed-Dose Combination of Rabeprazole and Sodium Bicarbonate (YPI-011) to the Conventional Enteric-Coated Rabeprazo... by Bae S, Kwon J, Lee MH, Yu KS, Lee S

    Published in Drug Design, Development and Therapy (2023-02-01)
    Get full text
    Article


  7. 7

    Pharmacokinetic Drug–Drug Interactions of DA-8010 with Clarithromycin or Rifampicin: Influence of CYP2D6 Phenotype on the Extent of These Interactions by Lee S, Won H, Yu KS, Lee DY, Lee S

    Published in Drug Design, Development and Therapy (2026-05-01)
    Get full text
    Article


  8. 8

    A Fixed-Dose Combination Of Gemigliptin And Rosuvastatin Exhibits Similar Pharmacokinetics, Pharmacodynamics, And Safety Compared To That Of A Loose Combination In Healthy Subjects by Kim E, Park KR, Jang IJ, Yu KS, Lee S

    Published in Drug Design, Development and Therapy (2019-11-01)
    Get full text
    Article


  9. 9

    Comparative Pharmacokinetics/Pharmacodynamics of Fixed-Dose Combination of Esomeprazole and Calcium Carbonate (AD-206) to the Conventional Esomeprazole by Bae S, Kwon J, Lee SB, Jang IJ, Yu KS, Lee S

    Published in Drug Design, Development and Therapy (2021-12-01)
    Get full text
    Article


  10. 10

    Pharmacokinetics and tolerability of MB12066, a beta-lapachone derivative targeting NAD(P)H:quinone oxidoreductase 1: two independent, double-blind, placebo-controlled, combined si... by Kim S, Lee S, Cho JY, Yoon SH, Jang IJ, Yu KS

    Published in Drug Design, Development and Therapy (2017-11-01)
    Get full text
    Article


  11. 11

    Population Pharmacokinetic and Pharmacodynamic Modeling of Enteric-Coated Aspirin Capsule and Tablet Formulations in Healthy Subjects by Koh J, Khwarg J, Yu KS, Lee S, Jang IJ, Lee S

    Published in Drug Design, Development and Therapy (2025-09-01)
    Get full text
    Article


  12. 12

    Pharmacokinetic/Pharmacodynamic Interaction Between Evogliptin and Pioglitazone in Healthy Male Subjects by Hwang I, Kim Y, Yoo H, Jang IJ, Yu KS, Lee S

    Published in Drug Design, Development and Therapy (2020-10-01)
    Get full text
    Article


  13. 13

    Pharmacokinetics of the evogliptin/metformin extended-release (5/1,000 mg) fixed-dose combination formulation compared to the corresponding loose combination, and food effect in he... by Rhee SJ, Lee S, Yoon SH, Cho JY, Jang IJ, Yu KS

    Published in Drug Design, Development and Therapy (2016-04-01)
    Get full text
    Article


  14. 14

    Safety, Tolerability and Pharmacokinetics of Intravenous Sodium Taurodeoxycholate, HY209, a GPCR19 Agonist Inhibiting Inflammasomal Activation by Chung WK, Jeon I, Jang IJ, Seong SY, Han SA, Yu KS

    Published in Drug Design, Development and Therapy (2024-12-01)
    Get full text
    Article


  15. 15

    Evaluation of the pharmacokinetic and pharmacodynamic drug interactions between cilnidipine and valsartan, in healthy volunteers by Lee J, Lee H, Jang K, Lim KS, Shin D, Yu KS

    Published in Drug Design, Development and Therapy (2014-10-01)
    Get full text
    Article


  16. 16

    Comparisons of the pharmacokinetics and tolerability of fixed-dose combinations of amlodipine besylate/losartan and amlodipine camsylate/losartan in healthy subjects: a randomized,... by Choi Y, Lee S, Cho SM, Kang WH, Nam KY, Jang IJ, Yu KS

    Published in Drug Design, Development and Therapy (2016-09-01)
    Get full text
    Article


  17. 17

    Comparison of the Pharmacokinetics, Safety, and Tolerability of Two Empagliflozin Formulations in Healthy Korean Subjects by Jiang X, Bae S, Yoon DY, Park SJ, Oh J, Cho JY, Yu KS

    Published in Drug Design, Development and Therapy (2023-07-01)
    Get full text
    Article


  18. 18

    Comparable pharmacokinetics and pharmacodynamics of two epoetin alfa formulations Eporon® and Eprex® following a single subcutaneous administration in healthy male voluntee... by Yoon S, Rhee SJ, Heo SJ, Oh TY, Yoon SH, Cho JY, Lee S, Yu KS

    Published in Drug Design, Development and Therapy (2017-10-01)
    Get full text
    Article


  19. 19

    Comparative steady-state pharmacokinetic study of an extended-release formulation of itopride and its immediate-release reference formulation in healthy volunteers by Yoon S, Lee H, Kim TE, Lee S, Chee DH, Cho JY, Yu KS, Jang IJ

    Published in Drug Design, Development and Therapy (2014-01-01)
    Get full text
    Article


  20. 20

    Pharmacokinetic and pharmacodynamic interactions between metformin and a novel dipeptidyl peptidase-4 inhibitor, evogliptin, in healthy subjects by Rhee SJ, Choi Y, Lee S, Oh J, Kim SJ, Yoon SH, Cho JY, Yu KS

    Published in Drug Design, Development and Therapy (2016-08-01)
    Get full text
    Article


Search Tools: